On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdaySep 14, 2021 9:00 am

Hypertension: The Silent Killer Making Loud Noise for Investors

NetworkNewsWire Editorial Coverage: Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about one out of every four have their condition under control. That’s a big problem considering hypertension increases risks for heart disease and stroke, which are, respectively, the no. 1 and no. 5 leading causes of death in the nation each year. To that point, the CDC names hypertension as a primary or contributing cause in nearly half a million deaths annually in the U.S. Hypertension treatment options vary tremendously from…

Continue Reading

TuesdaySep 14, 2021 9:00 am

Digital Media — The Next Generation: AI, Social for Video and Content to Web Ad Commerce

NetworkNewsWire Editorial Coverage: Look a little closer, and it’s clear that the world has entered a major global inflection point in the modern history of digital media. This new era of digital media is set to reshape the future of social fabric and revolutionize how brands connect with their consumers. The increasing innovation and intelligence in digital media tactics and strategies is making consumer messaging amazingly native and relevant. This personable approach  to online consumer targeting is providing ways to better serve brands by connecting to current and potential target consumers while cutting through the noise. As recently as 2019,…

Continue Reading

MondaySep 13, 2021 2:59 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Impressive Blood Pressure Reduction in Hypertension Clinical Trials

Lexaria Bioscience has developed a patented technology that improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing Lexaria’s patented DehydraTECH (TM) technology is undergoing human clinical trials this year to determine its effectiveness in making cannabidiol (“CBD”) effective as a means of reducing blood pressure for high blood pressure patients The initial results of the first human clinical study showed the DehydraTECH-CBD compound was well tolerated by patients without troubling side effects and that the compound outperformed generic CBD controls Just-released initial (partial) results regarding the compound’s second human clinical trial show that a three-dose regimen…

Continue Reading

MondaySep 13, 2021 2:06 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), Innovation, Partnerships, and Leadership: A 2021 Outlook

So far in 2021, Tryp’s innovations have allowed it to position itself as a first-mover in the psychedelics space The company has announced completion of psychotherapy training for the upcoming phase 2a clinical trials for specific overeating disorders Tryp has also been keen on collaborating and partnering with key players in the industry, such as Calvert Labs and Gad Consulting services, the University of Michigan, and the University of Florida  The company also understands the value of proper leadership and, so far in 2021, it has made strategic appointments to its board of directors Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF)…

Continue Reading

MondaySep 13, 2021 1:43 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Empowering Pharmacists to Better Help Family Physicians and Patients

Through HealthTab, its flagship offering, Avricore turns pharmacies into community diagnostic centers by providing a turnkey point-of-care testing platform HealthTab is a multilayered operational ecosystem that provides endless possibilities, from lab-accurate tests to immediate results uploaded automatically on a web-based platform It enables patients to review the results on the spot with the pharmacist, allowing pharmacists to take on a more significant role in primary health services HealthTab ultimately aims to improve the quality of life for patients living with chronic illnesses A recent McKinsey article observed that consumers deeply care about wellness now more than ever; this interest is…

Continue Reading

MondaySep 13, 2021 1:36 pm

reAlpha Set to Advance Innovative Short-Term Rental Platform Following $6 Million Investment Round

The $6 million investment round was led by Crawford Hoying, a real estate holding company with more than $1.3 billion of mixed-use, multifamily, office, and retail properties The company is taking advantage of the new wave of investment opportunities in the emerging industry Airbnb has created  Equity in reAlpha properties can be purchased for as little as $2,500 and handled much like buying stock in a company. Investors are matched with like-minded backers to cover the down payment on properties reAlpha, often referred to as the Robinhood of Airbnb investments, recently announced that it has closed on a $6 million…

Continue Reading

MondaySep 13, 2021 1:19 pm

DGE’s 7th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare – Virtual Conference On Women Leadership Roles

Date: September 22-24, 2021 Online Livestream Pharma professionals, healthcare providers, influencers, and healthcare-related industries are invited to attend DGE’s 7th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare being held on September 22-24, 2021, as a live online event. The event is organized by Dynamic Global Events (“DGE”), a Life Science leader in hosting B2B events. This global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.  Women executives in the pharma and healthcare sector face numerous hurdles to reach the echelon of success. The event will feature such…

Continue Reading

MondaySep 13, 2021 1:02 pm

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Files for National Medical Products Administration Registration of Early-Warning Cancer Technology with a Record 11 Tumor Types Under Formal Medical Device Product Registration

AnPac Bio-Medical Science Co., Ltd. has developed its proprietary Cancer Differentiation Analysis (“CDA”) technology to detect biophysical signals as an alternative early disease indicator to blood-based biomarker testing for cancer The company has laboratories and R&D facilities in China equipped for CDA testing and cancer biochemical testing, as well as a CLIA/CAP accredited laboratory in the United States  AnPac Bio recently held its 2021 technical symposium in China where KOLs from major hospitals and universities discussed new technologies for cancer detection and treatment. AnPac Bio-Medical Science (NASDAQ: ANPC) is moving forward with testing and registration of its multi-cancer screening technology…

Continue Reading

MondaySep 13, 2021 11:59 am

Flora Growth Corp. (NASDAQ: FLGC) Expands Across International Borders into Europe and Asia

Flora Growth business divisions include pharmaceuticals, cosmetics, hemp textiles, and food & beverage sectors Flora Lab now has three GMP certifications – one each for cosmetics, phytotherapeutic products, and dietary supplements Flora Growth operates internationally but has its cultivation and processing operations based in Colombia – with one of the largest outdoor cultivation facilities in the world, aiming to produce medical-grade cannabis flower and derivative products at below-market pricing Proposed acquisitions of Vessel Brand and Koch & Gsell, as well as investment into Hoshi International, will help expand the business across international borders and into the US, Europe, and Asia…

Continue Reading

MondaySep 13, 2021 10:31 am

Audio Broadcast Presents Off-peak Electricity Analysis Results Commissioned by FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) to Boost Carbon-free Ammonia IP

FuelPositive Corp. is a Canadian-based clean energy solutions innovator developing a means of using green ammonia as a non-carbon polluting fuel  The company was recently featured in a broadcast by NetworkNewsAudio (“NNA”) that highlights FuelPositive’s advances in making green ammonia more portable, more cost-efficient and ultimately more power generating than environmentalist darling hydrogen The broadcast notes that traditional ammonia production typically creates significant pollution, but that the key advantage of FuelPositive’s Phase 2 Hydrogen-Ammonia Synthesizer is that it eliminates the pollution factor and makes carbon free ammonia easy to produce where needed as a transportation fuel The broadcast highlights the…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217